Holen Sie sich die Stockscreener-App
5.27
2.53%
0.13
Schlusskurs vom Vortag:
$5.14
Offen:
$5.17
24-Stunden-Volumen:
1.02M
Relative Volume:
0.80
Marktkapitalisierung:
$732.09M
Einnahmen:
$62.04M
Nettoeinkommen (Verlust:
$-533.34M
KGV:
-1.3444
EPS:
-3.92
Netto-Cashflow:
$-473.07M
1W Leistung:
+6.68%
1M Leistung:
+3.13%
6M Leistung:
-35.89%
1J Leistung:
-31.11%
1-Tages-Spanne:
$5.095
$5.3381
1-Wochen-Bereich:
$4.87
$5.638
52-Wochen-Spanne:
$4.155
$14.45
Vir Biotechnology Inc Stock (VIR) Company Profile
Firmenname
Vir Biotechnology Inc
Sektor
Branche
Telefon
415-906-4324
Adresse
1800 OWENS STREET, SAN FRANCISCO, CA
Vergleichen Sie VIR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VIR
Vir Biotechnology Inc
|
5.27 | 714.03M | 62.04M | -533.34M | -473.07M | -3.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Vir Biotechnology Inc Stock (VIR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Eingeleitet | Evercore ISI | Outperform |
| 2025-08-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2024-01-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-09-08 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-03-06 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-02-21 | Hochstufung | Goldman | Neutral → Buy |
| 2023-01-27 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2022-09-14 | Eingeleitet | SVB Leerink | Outperform |
| 2022-09-09 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-03-03 | Hochstufung | Robert W. Baird | Underperform → Neutral |
| 2021-12-21 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2021-10-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2021-09-22 | Herabstufung | Goldman | Buy → Neutral |
| 2021-06-04 | Fortgesetzt | Robert W. Baird | Neutral |
| 2021-01-27 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-01-20 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-05 | Eingeleitet | BofA Securities | Buy |
| 2020-09-14 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-11 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-08-20 | Eingeleitet | Needham | Buy |
| 2020-03-19 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-13 | Herabstufung | Goldman | Buy → Neutral |
| 2020-02-27 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-02-04 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-11-14 | Eingeleitet | Robert W. Baird | Neutral |
| 2019-11-05 | Eingeleitet | Barclays | Overweight |
| 2019-11-05 | Eingeleitet | Cowen | Outperform |
| 2019-11-05 | Eingeleitet | Goldman | Buy |
| 2019-11-05 | Eingeleitet | JP Morgan | Overweight |
Alle ansehen
Vir Biotechnology Inc Aktie (VIR) Neueste Nachrichten
Vir Biotechnology Inc. stock momentum explainedMarket Activity Report & AI Driven Stock Reports - Newser
Real time social sentiment graph for Vir Biotechnology Inc.Quarterly Earnings Summary & Verified Momentum Stock Ideas - Newser
Using fundamentals and technicals on Vir Biotechnology Inc.Earnings Performance Report & Accurate Buy Signal Notifications - Newser
What is Vir Biotechnology Inc. s revenue forecastJuly 2025 Pullbacks & Low Risk Entry Point Guides - 강소기업뉴스
How to integrate Vir Biotechnology Inc. into portfolio analysis toolsJuly 2025 Big Picture & Accurate Intraday Trading Signals - Newser
Technical signs of recovery in Vir Biotechnology Inc.Weekly Stock Report & Weekly Breakout Opportunity Watchlist - Newser
Analyzing net buyer seller activity in Vir Biotechnology Inc.Market Risk Analysis & Free Low Drawdown Momentum Trade Ideas - Newser
Forecasting Vir Biotechnology Inc. price range with options dataJuly 2025 Pullbacks & Low Volatility Stock Suggestions - Newser
Vir Biotechnology Inc. stock prediction for this weekCEO Change & AI Based Buy and Sell Signals - Newser
Is Vir Biotechnology Inc. subject to activist investor interestMarket Rally & Growth Focused Entry Reports - خودرو بانک
What are Vir Biotechnology Inc.’s growth levers2025 Pullback Review & Weekly High Potential Stock Alerts - خودرو بانک
Trend analysis for Vir Biotechnology Inc. this weekJuly 2025 Closing Moves & Technical Pattern Based Buy Signals - Newser
Why Vir Biotechnology Inc. stock attracts strong analyst attentionWeekly Market Report & Advanced Swing Trade Entry Plans - Newser
What earnings revisions data tells us about Vir Biotechnology Inc.July 2025 Short Interest & Weekly Breakout Opportunity Watchlist - Newser
Can Vir Biotechnology Inc. recover in the next quarterTrade Volume Summary & Daily Stock Trend Watchlist - Newser
Vir Biotechnology Inc. stock outlook for YEAR2025 Market Sentiment & Weekly Stock Breakout Alerts - Newser
Using data tools to time your Vir Biotechnology Inc. exitJuly 2025 PreEarnings & Weekly Breakout Opportunity Watchlist - Newser
Earnings Update: What is Vir Biotechnology Inc. s revenue forecastRecession Risk & Free Fast Gain Swing Trade Alerts - خودرو بانک
Vir Biotechnology's Sharp Intraday Drop: What's Behind the Move? - AInvest
Is it time to cut losses on Vir Biotechnology Inc.Portfolio Risk Summary & Real-Time Market Trend Scan - Newser
Using Bollinger Bands to evaluate Vir Biotechnology Inc.2025 Short Interest & Real-Time Volume Trigger Notifications - Newser
Historical volatility pattern of Vir Biotechnology Inc. visualizedTrade Performance Summary & Low Volatility Stock Suggestions - Newser
Vir Biotechnology: A Contrarian Buy in a High-Risk, High-Reward Biotech Play - AInvest
The Play On Vir Biotechnology (NASDAQ:VIR) - Seeking Alpha
Sato Vicki L, Vir Biotechnology director, sells $109k in shares - Investing.com Canada
Vir Biotechnology (VIR.O) Surges 7.3%—What’s Behind the Intraday Move? - AInvest
Vir Biotechnology Director Sells 22K Shares at $4.99 on 2025-09-02. - AInvest
Vir Biotechnology Surges 5.1% — But No Technical Signals Fired — Here’s What Could Be Behind It - AInvest
Should you wait for a breakout in Vir Biotechnology Inc.Market Weekly Review & Verified Chart Pattern Trade Signals - Newser
Analyzing recovery setups for Vir Biotechnology Inc. investors2025 Market Sentiment & Smart Investment Allocation Tips - Newser
What are the analyst revisions for Vir Biotechnology Inc.Is LBTYB stock a good investment in YEAR2025 Top Gainers & Weekly High Conviction Trade Ideas - خودرو بانک
Evercore ISI initiates coverage on Vir Biotechnology with Outperform rating, $12 PT. - AInvest
Evercore ISI initiates Vir Biotechnology stock with Outperform rating - Investing.com
How sentiment analysis helps forecast Vir Biotechnology Inc.Weekly Profit Summary & Real-Time Buy Signal Notifications - Newser
Hedge Fund Bets: Will Vir Biotechnology Inc. outperform the market in YEARMarket Performance Report & Low Drawdown Investment Ideas - خودرو بانک
What to expect from Vir Biotechnology Inc. in the next 30 daysPortfolio Update Summary & Proven Capital Preservation Methods - Newser
Heatmap analysis for Vir Biotechnology Inc. and competitorsMarket Risk Analysis & Free Low Drawdown Momentum Trade Ideas - Newser
What MACD signals say about Vir Biotechnology Inc.Dip Buying & AI Enhanced Trading Alerts - Newser
Does Vir Biotechnology Inc. stock benefit from AI growthJuly 2025 Movers & Fast Gaining Stock Strategy Reports - خودرو بانک
Finanzdaten der Vir Biotechnology Inc-Aktie (VIR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):